Global Artificial Heart Lung Machines Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch＇s in-depth investigation and research, the global Artificial Heart Lung Machines market size will reach 323.88 Million USD in 2025 and is projected to reach 414.58 Million USD by 2032, with a CAGR of 3.59% (2025-2032). Notably, the China Artificial Heart Lung Machines market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be  Million USD, representing approximately  % of the global market share.

Research Summary

Artificial Heart Lung Machines, also known as cardio-pulmonary bypass machines, are medical devices that temporarily take over the function of the heart and lungs during cardiac surgery. They are used to circulate and oxygenate the blood bypassing the heart and lungs while the heart is stopped to perform surgical procedures such as bypass grafts, valve replacements, heart transplants, and others. The machine pumps oxygenated blood from the lungs back into the body, allowing the heart to be stopped and repaired without causing severe organ damage. The use of artificial heart-lung machines has revolutionized cardiac surgery, enabling complex procedures to be performed safely.

The major global  manufacturers of Artificial Heart Lung Machines include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, Tianjin Medical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Artificial Heart Lung Machines. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Artificial Heart Lung Machines market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Artificial Heart Lung Machines market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Artificial Heart Lung Machines industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Artificial Heart Lung Machines Include:

LivaNova (Sorin)

Getinge (Maquet)

Medtronic

Terumo CV Group

Braile Biomedica

Tianjin Medical

Artificial Heart Lung Machines Product Segment Include:

Single Roller Pump HLM

Double Roller Pump HLM

Artificial Heart Lung Machines Product Application Include:

Cardiac Surgery

Lung Transplant Operation

Acute Respiratory Failure Treatment

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Artificial Heart Lung Machines Industry PESTEL Analysis

Chapter 3: Global Artificial Heart Lung Machines Industry Porter's Five Forces Analysis

Chapter 4: Global Artificial Heart Lung Machines Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis

Chapter 5: Global Artificial Heart Lung Machines Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 6: Global Artificial Heart Lung Machines Sales, Revenue, Price and Forecast by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 8: Industrial Chain Analysis, Artificial Heart Lung Machines Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources Show more